Research Article


DOI :10.26650/experimed.1500881   IUP :10.26650/experimed.1500881    Full Text (PDF)

Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening

Deniz ŞahinZeynep KanlıdereBarışcan EkalBerkehür AbaylıYordan HayatEce Selçuk

Objective: Colorectal cancer ranks among the most frequently occurring cancers. Addressing the diagnosis and treatment challenges requires the advancement of alternative approaches that can more precisely differentiate between cancerous and healthy cells.

Materials and Methods: We identified colon cancer cell surface specific 12-mer peptides using subtractive phage display technique. Four rounds of biopanning were conducted using the M13 bacteriophage PhD-12 peptide library with the human colon cancer cell line HCT-116. Subtractive selection involved the use of the human rectal cancer cell line SW837 and the healthy CCD112-CoN cell line. Binding levels of selected phage clones were tested by ELISA-HRP binding assays. Experimentally identified peptide sequences were synthesized by solid-phase chemistry. Peptides were labelled at the N-terminus with a fluorescent dye for visualization of cells by confocal microscopy.

Results: Peptide COL419 (Serine-Valine-Alanine-Histidine-Leucine-Serine-Proline-Histidine-Serine-Threonine-Threonine-Alanine; SVAHLSPHSTTA) can differentiate colon and rectal cancers from healthy cells. In addition, the COL-AA peptide (Histidine-Tyrosine-Proline Threonine-Asparagine-Leucine-Histidine-Tyrosine-Proline-Threonine-Asparagine-Leucine; HYPTNLHYPTNL), which was designed from the amino acid composition analysis of the experimentally selected peptide sequences bound to colon cancer cells and neither rectal cancer cells nor healthy colorectal cells.

Conclusion: The peptides determined specifically target colon cancer cells. These findings enhance our understanding of the differences between these cancer types. The selected peptides have the potential for clinical application in targeted diagnosis and treatment of colon cancer.


PDF View

References

  • 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-49. google scholar
  • 2. Paschke S, Jafarov S, Staib L, Kreuser ED, Maulbecker-Armstrong C, Roitman M, et al. Are colon and rectal cancer two different tumor entities? A proposal to abandon the term colorectal cancer. Int J Mol Sci 2018; 19(9): 2577. google scholar
  • 3. Dmitrieva MD, Voitova AA, Dymova MA, Richter VA, Kuligina EV. Tumor-targeting peptides search strategy for the delivery of therapeutic and diagnostic molecules to tumor cells. Int J Mol Sci 2020; 22(1): 314. google scholar
  • 4. Raucher D. Tumor targeting peptides: novel therapeutic strategies in glioblastoma. Curr Opin Pharmacol 2019; 47: 14-19. google scholar
  • 5. Liu R, Li X, Xiao W, Lam KS. Tumor-targeting peptides from combinatorial libraries. Adv Drug Deliv Rev 2017; 110: 13-37. google scholar
  • 6. Kehoe JW, Kay BK. Filamentous phage display in the new millennium. Chem rev 2005; 105(11); 4056-72. google scholar
  • 7. Zhang ZF, Shan X, Wang YX, Wang W, Feng SY, Cui YB. Screening and selection of peptides specific for esophageal cancer cells from a phage display peptide library. J Cardiothorac Surg 2014; 9: 1-7. google scholar
  • 8. Lü X, Yao M, Zhang JM, Yang J, Lei YF, Huang XJ, Yin W. Identification of peptides that bind hepatitis C virus envelope protein E2 and inhibit viral cellular entry from a phage-display peptide library. Int J Mol Med 2014; 33(5): 1312-8. google scholar
  • 9. Perez-Martı'nez D, Infante YC, Ramurez BS, Rojas G. Domain-level epitope mapping of polyclonal antibodies against HER-1 and HER-2 receptors using phage display technology. Sci Rep 2022; 12(1): 12268. google scholar
  • 10. Sahin D, Taflan SO, Yartas G, Ashktorab H, Smoot DT. Screening and identification of peptides specifically targeted to gastric cancer cells from a phage display peptide library. APJCP 2018; 19(4): 927. google scholar
  • 11. Rojas G, Tundidor Y, Infante YC. High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surface. MAbs 2014; 6(6): 1368-76. google scholar
  • 12. Sun J, Zhang C, Liu G, Liu H, Zhou C, Lu Y, Li X. A novel mouse CD133 binding-peptide screened by phage display inhibits cancer cell motility in vitro. Clin Exp Met 2012; 29: 185-96. google scholar
  • 13. Thundimadathil J. Cancer treatment using peptides: current therapies and future prospects. J Amino Acids 2012; 2012: 967347. Peer-review: Externally peer-reviewed. google scholar
  • 14. Zhang D, Huang J, Li W, Zhang Z, Zhu M, Feng Y, He S. Screening and identification of a CD44v6 specific peptide using improved phage display for gastric cancer targeting. Ann Transl Med 2020; 8: 21. google scholar
  • 15. Panagides N, Zacchi LF, De Souza MJ, Morales RAV, Karnowski A, Liddament MT, et al. Evaluation of phage display biopanning strategies for the selection of anti-cell surface receptor antibodies. Int J Mol Sci 2022; 23(15): 8470. google scholar
  • 16. Freund NT, Enshell-Seijffers D, Gershoni JM. Phage display selection, analysis, and prediction of B cell epitopes. Curr Protoc Immunol 2009; 86(1): 9-8. google scholar
  • 17. Hou L, Zhu D, Liang Y, Tian X, Li L, Wang P, Meng X. Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library. Br J Cancer 2018; 118(1): 79-87. google scholar
  • 18. Kwak MH, Yi G, Yang SM, Choe Y, Choi S, Lee HS, Park JM. A dodecapeptide selected by phage display as a potential theranostic probe for colon cancers. Transl Oncol 2020; 13(9): 100798. google scholar
  • 19. Kelly KA, Jones DA. Isolation of a colon tumor specific binding peptide using phage display selection. Neoplasia 2003; 5(5): 437-44. google scholar
  • 20. Ferreira D, Silva AP, Nobrega FL, Martins IM, Barbosa-Matos C, Granja S, et al. Rational identification of a colorectal cancer targeting peptide through phage display. Sci Rep 2019; 9(1): 3958. google scholar
  • 21. Bakhshinejad B, Sadeghizadeh M. Identification of a novel colon adenocarcinoma cell targeting peptide using phage display library biopanning. Biotechnol Appl Biochem 2022; 69(6): 2753-65. google scholar
  • 22. Zhang Y, Chen J, Zhang Y, Pan Y, Zhao J, Ren L, et al. A novel PEGylation of chitosan nanoparticles for gene delivery. Biotechnol Appl Bioc 2007; 46(4): 197-204. google scholar
  • 23. Yu X, Yan J, Chen X, Wei J, Yu L, Liu F, et al. Identification of a peptide binding to cancer antigen Kita Kyushu lung cancer antigen 1 from a phage-display library. Cancer Science 2021; 112(10): 4335-45. google scholar
  • 24. Bakhshinejad B, Sadeghizadeh M. Identification of a novel colon adenocarcinoma cell targeting peptide using phage display library biopanning. Biotechnol Appl Biochem 2022; 69(6): 2753-65. google scholar

Citations

Copy and paste a formatted citation or use one of the options to export in your chosen format


EXPORT



APA

Şahin, D., Kanlıdere, Z., Ekal, B., Abaylı, B., Hayat, Y., & Selçuk, E. (2024). Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening. Experimed, 14(3), 174-182. https://doi.org/10.26650/experimed.1500881


AMA

Şahin D, Kanlıdere Z, Ekal B, Abaylı B, Hayat Y, Selçuk E. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening. Experimed. 2024;14(3):174-182. https://doi.org/10.26650/experimed.1500881


ABNT

Şahin, D.; Kanlıdere, Z.; Ekal, B.; Abaylı, B.; Hayat, Y.; Selçuk, E. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening. Experimed, [Publisher Location], v. 14, n. 3, p. 174-182, 2024.


Chicago: Author-Date Style

Şahin, Deniz, and Zeynep Kanlıdere and Barışcan Ekal and Berkehür Abaylı and Yordan Hayat and Ece Selçuk. 2024. “Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening.” Experimed 14, no. 3: 174-182. https://doi.org/10.26650/experimed.1500881


Chicago: Humanities Style

Şahin, Deniz, and Zeynep Kanlıdere and Barışcan Ekal and Berkehür Abaylı and Yordan Hayat and Ece Selçuk. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening.” Experimed 14, no. 3 (Dec. 2024): 174-182. https://doi.org/10.26650/experimed.1500881


Harvard: Australian Style

Şahin, D & Kanlıdere, Z & Ekal, B & Abaylı, B & Hayat, Y & Selçuk, E 2024, 'Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening', Experimed, vol. 14, no. 3, pp. 174-182, viewed 21 Dec. 2024, https://doi.org/10.26650/experimed.1500881


Harvard: Author-Date Style

Şahin, D. and Kanlıdere, Z. and Ekal, B. and Abaylı, B. and Hayat, Y. and Selçuk, E. (2024) ‘Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening’, Experimed, 14(3), pp. 174-182. https://doi.org/10.26650/experimed.1500881 (21 Dec. 2024).


MLA

Şahin, Deniz, and Zeynep Kanlıdere and Barışcan Ekal and Berkehür Abaylı and Yordan Hayat and Ece Selçuk. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening.” Experimed, vol. 14, no. 3, 2024, pp. 174-182. [Database Container], https://doi.org/10.26650/experimed.1500881


Vancouver

Şahin D, Kanlıdere Z, Ekal B, Abaylı B, Hayat Y, Selçuk E. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening. Experimed [Internet]. 21 Dec. 2024 [cited 21 Dec. 2024];14(3):174-182. Available from: https://doi.org/10.26650/experimed.1500881 doi: 10.26650/experimed.1500881


ISNAD

Şahin, Deniz - Kanlıdere, Zeynep - Ekal, Barışcan - Abaylı, Berkehür - Hayat, Yordan - Selçuk, Ece. Identification of Peptides Binding Specifically to Colon Cancer Cells through Phage Display Peptide Library Screening”. Experimed 14/3 (Dec. 2024): 174-182. https://doi.org/10.26650/experimed.1500881



TIMELINE


Submitted27.06.2024
Accepted04.10.2024
Published Online02.12.2024

LICENCE


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


SHARE




Istanbul University Press aims to contribute to the dissemination of ever growing scientific knowledge through publication of high quality scientific journals and books in accordance with the international publishing standards and ethics. Istanbul University Press follows an open access, non-commercial, scholarly publishing.